Breaking News
Sort by:
Top Post
Babylon GP At Hand Opens Two News Clinics For London Patients
Babylon GP at Hand has opened two new clinics situated in London that will provide […]
CHOP Researchers Develop New Computational Tool to Interpret Clinical Significance of Cancer Mutations
Researchers at Children’s Hospital of Philadelphia (CHOP) have developed a new tool to help researchers interpret […]
Twice-yearly Injection to Treat High Blood Pressure Could Replace Daily Pills
If successful, the study by Queen Mary University of London and Barts Health NHS Trust […]
Mobile Cataract Units and Same-day Hip Replacements Helping Thousands Get NHS Treatment
Same-day hip replacements, one stop shops and mobile cataract units are just some of the […]
Minnesota Neurosurgeon Among First in Country to Perform Navigated Spine Fusions With Inspired Spine OLLIF Technology | Pharmtech Focus
Dr. Uzma Samadani, A Minneapolis neurosurgeon renowned for spine tumor resection and complex neurotrauma repair has completed 4 […]
Canadian North York General Hospital Chooses Enterprise Imaging Solution from Sectra to Improve Radiology Workflows
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a contract with North […]
European Healthtech Mindgram Closes €7 Million Seed Round and Begins Its European Expansion
Mindgram, the European B2B platform providing integrated support for employees in the well-being sphere, has […]
Arrayjet Introduces Mercury Range of Next-generation Microarray Printers
Arrayjet, a leading provider of inkjet liquid-handling solutions, today introduced Mercury, a new core range of […]
Evonetix Granted Patent for Technology Enabling Thermally-controlled DNA Synthesis
EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced […]
Structure of a Bacterial "Drug Pump" Reveals New Way to Counter Hospital-borne Infection
By revealing the structure of a protein used by bacteria to pump out antibiotics, a […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more